Adrenal Crisis

According to long-term studies, patients with adrenal insufficiency (AI) exhibit a reduced quality of life and increased mortality. In addition to cardiovascular and malignant diseases, the risk of mortality is particularly increased by adrenal crises. Fatal adrenal crises could be completely preven...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Deutsche medizinische Wochenschrift (1946) Ročník 150; číslo 15; s. 865
Hlavní autor: Weismann, Dirk
Médium: Journal Article
Jazyk:němčina
Vydáno: Germany 01.08.2025
Témata:
Adrenal Insufficiency - diagnosis
Adrenal Insufficiency - drug therapy
Adrenal Insufficiency - mortality
Diagnosis, Differential
Glucocorticoids - therapeutic use
Humans
ISSN:1439-4413, 1439-4413
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:According to long-term studies, patients with adrenal insufficiency (AI) exhibit a reduced quality of life and increased mortality. In addition to cardiovascular and malignant diseases, the risk of mortality is particularly increased by adrenal crises. Fatal adrenal crises could be completely prevented by timely intravenous or subcutaneous administration of glucocorticoids. In the case of an established diagnosis of AI, a deterioration in the general condition, gastroenteritis symptoms, exsiccosis and a clinical picture of sepsis must lead to the suspicion of an adrenal crisis. However, the diagnosis is only confirmed by the response to glucocorticoids. So-called check-point inhibitors are becoming increasingly important as a cause of AI. Therefore, AI and adrenal crises continue to pose a challenge for patients, their relatives and the treating physicians.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1439-4413
1439-4413
DOI:10.1055/a-2318-7541